Regenerex Pharma (RGPX) Current Assets (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Current Assets data on file, last reported at $48429.0 in Q3 2025.

• Current Assets for Q3 2025 came in at $48429.0, up 2539.18% year-over-year; the trailing twelve-month figure through Sep 2025 was $48429.0 (up 2539.18% YoY), and the FY2025 annual result was $653375.0, up 22337.33% from the prior year.
• Current Assets retreated to $48429.0 in Q3 2025 per RGPX's latest filing, from $192680.0 in the prior quarter.
• Over five years, Current Assets peaked at $653375.0 in Q1 2025 and troughed at $988.0 in Q4 2024.
• A 5-year average of $56199.5 and a median of $5381.0 in 2021 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2025: Current Assets plunged 98.88% in 2021, then soared 22337.33% in 2025.
• A 5-year view of Current Assets shows it stood at $2789.0 in 2021, then jumped by 32.77% to $3703.0 in 2022, then soared by 150.58% to $9279.0 in 2023, then tumbled by 89.35% to $988.0 in 2024, then soared by 4801.72% to $48429.0 in 2025.
• Business Quant data shows RGPX's Current Assets at $48429.0 in Q3 2025, $192680.0 in Q2 2025, and $653375.0 in Q1 2025.